MA
NVO

Montag & Associates’s Novo Nordisk NVO Stock Holding History

Montag & Associates’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.92K Buy
82
+15
+22% +$644 ﹤0.01% 823
2026
Q1 		$2.54K Hold
67
– – ﹤0.01% 828
2025
Q4 		$3.43K Sell
67
-61
-48% -$3.12K ﹤0.01% 837
2025
Q3 		$7.09K Sell
128
-9,274
-99% -$543K ﹤0.01% 795
2025
Q2 		$649K Hold
9,402
– – 0.03% 284
2025
Q1 		$660K Hold
9,402
– – 0.03% 285
2024
Q4 		$809K Sell
9,402
-1,286
-12% -$139K 0.04% 264
2024
Q3 		$1.27M Sell
10,688
-1,105
-9% -$147K 0.06% 224
2024
Q2 		$1.68M Buy
11,793
+506
+4% +$67.1K 0.08% 182
2024
Q1 		$1.46M Buy
11,287
+1,795
+19% +$214K 0.07% 210
2023
Q4 		$982K Buy
9,492
+96
+1% +$9.49K 0.05% 230
2023
Q3 		$854K Hold
9,396
– – 0.05% 235
2023
Q2 		$760K Sell
9,396
-4
-0% -$327 0.05% 246
2023
Q1 		$752K Hold
9,400
– – 0.05% 243
2022
Q4 		$636K Buy
9,400
+50
+0.5% +$2.93K 0.04% 241
2022
Q3 		$466K Hold
9,350
– – 0.03% 265
2022
Q2 		$521K Hold
9,350
– – 0.03% 259
2022
Q1 		$519K Hold
9,350
– – 0.03% 286
2021
Q4 		$524K Hold
9,350
– – 0.03% 292
2021
Q3 		$449K Hold
9,350
– – 0.02% 302
2021
Q2 		$392K Hold
9,350
– – 0.02% 311
2021
Q1 		$315K Hold
9,350
– – 0.02% 331
2020
Q4 		$327K Buy
+9,350
New +$323K 0.02% 310

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Montag & Associates's NVO Position: Q2 2026 in Review

Montag & Associates increased its Novo Nordisk (NVO) stake by 22% in Q2 2026, buying an estimated $644 and bringing the position to 82 shares worth $3.92K. The position accounts for ﹤0.01% of the portfolio, ranked #823.

Montag & Associates first reported a position in NVO in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.68M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Montag & Associates held 82 shares of Novo Nordisk worth $3.92K as of Q2 2026.
  • Montag & Associates bought 15 Novo Nordisk shares in Q2 2026, an estimated $644.
  • Novo Nordisk made up ﹤0.01% of Montag & Associates's portfolio in Q2 2026, its #823 holding.
  • Montag & Associates first reported a position in Novo Nordisk in Q4 2020 and has held it in 23 quarters since.
  • Montag & Associates's Novo Nordisk position peaked at $1.68M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Montag & Associates's 13F filing for Q2 2026, filed 5 Aug 2026.